Acceleron Pharma reported $35.47M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Akebia Therapeutics AKBA:US $ 41.65M 323K
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.38B 130M
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Bayer BAYN:GR 3.75B 226M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Clovis Oncology CLVS:US $ 32.92M 2.98M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eli Lilly And LLY:US $ 1.69B 109.7M
Exelixis EXEL:US $ 98.49M 3.86M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Rigel Pharmaceuticals RIGL:US $ 22.38M 257K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
United Therapeutics UTHR:US $ 112.8M 2.9M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M